Intravitreal dexamethasone implant for a vitrectomized eye with diabetic macular edema

Taiwan Journal of Ophthalmology

Volumn 3, Issue 4, 2013, Pages 163-167

  Chen, Tsu Hua ^a   Wang, Jia Kang ^a,b,c   Chang, Shu Wen ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Diabetic macular edema; Intravitreal dexamethasone implant; Ozurdex; Vitrectomized eye

Indexed keywords

EID: 84890303051     PISSN: 22115056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tjo.2013.04.005     Document Type: Article

References (19)

1. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet 2010, 376:124-136.
2. Nguyen Q.D., Tatlipinar S., Shah S.M., Haller J.A., Quinlan E., Sung J., et al. Vascular endothelial growth factor is a critical stimulus for diabetic macular edema. Am J Ophthalmol 2006, 142:961-969.
3. Beck R.W., Edwards A.R., Aiello L.P., Bressler N.M., Ferris F., et al. Three-year follow up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema. Arch Ophthalmol 2009, 127:245-251. Diabetic Retinopathy Clinical Research Network.
4. Arevalo J.F., Sanchez J.G., Wu L., Maia M., Alezzandrini A.A., Brito M., et al. Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 Months. Ophthalmology 2009, 116:1488-1497.
5. Haller J.A., Bandello F., Belfort R., Blumenkranz M.S., Gillies M., Heier J., et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology 2011, 118:2453-2460.
6. Lowder C., Belfort R., Lightman S., Foster C.S., Robinson M.R., Schiffman R.M., et al. Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis. Arch Ophthalmol 2011, 129:545-553.
7. Zucchiatti I., Lattanzio R., Querques G., Querques L., Turco C.D., Cascavilla M.L., et al. Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 2012, 228:117-122.
8. Boyer D.S., Faber D., Gupta S., Patel S.S., Tabandeh H.Y., Li X.Y., et al. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina 2011, 31:915-923.
9. Rishi P., Rishi E., Kuniyal L., Mathur G. Short-term results of intravitreal dexamethasone implant (OZURDEX_) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol 2012, 5:79-82.
10. Yeh P.T., Yang C.M., Yang C.H., Huang J.S. Cryotherapy of the anterior retina andsclerotomy sites in diabetic vitrectomy to prevent recurrent vitreous hemorrhage: an ultrasound biomicroscopy study. Ophthalmology 2005, 112:2095-2102.
11. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Arch Ophthalmol 1985, 103:1796-1806. Early Treatment Diabetic Retinopathy Study Research Group.
12. Yilmaz T., Weaver C.D., Gallagher M.J., Cordero-Coma M., Cervantes-Castaneda R.A., Klisovic D., et al. Intravitreal triamcinolone acetonide injection for treatment of refractory diabetic macular edema: a systematic review. Ophthalmology 2009, 116:902-913.
13. Kakinoki M., Sawada O., Sawada T., Saishin Y., Kawamura H., Ohji M. Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys. Invest Ophthalmol Vis Sci 2012, 53:5877-5880.
14. Chin H.S., Park T.S., Moon Y.S., Oh J.H. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes. Retina 2005, 25:556-560.
15. Beer P.M., Bakri S.J., Singh R.J., Liu W., Peters G.B., Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003, 110:681-686.
16. Yanyali A., Aytug B., Horozoglu F., Nohutcu A.F. Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes. Am J Ophthalmol 2007, 144:124-126.
17. Welty D., Kuppermann B.D., Chang-lin J.E. Dexamethasone posterior segment drug delivery system: pharmacokinetics in vitrectomized and non-vitrectomized eyes. Paper presented at 25th Annual Meeting of the American Society of Retina Specialists 2007, Indian Wells, CA. Abstract 3597.
18. Cardillo J.A., Melo L.A., Costa R.A., Skaf M., Belfort R., Souza-Filho A.A., et al. Comparison of intravitreal versus posterior sub-tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005, 112:1557-1563.
19. Googe J., Brucker A.J., Bressler N.M., Qin H., Aiello L.P., et al. Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema following focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation. Retina 2011, 31:1009-1027. Diabetic Retinopathy Clinical Research Network.